Pages that link to "Q42734045"

The following pages link to β-arrestin deficiency protects against pulmonary fibrosis in mice and prevents fibroblast invasion of extracellular matrix (Q42734045):

Displaying 48 items.

• The emerging roles of β-arrestins in fibrotic diseases (Q26783047) (← links)
• Multifaceted role of β-arrestins in inflammation and disease (Q26785883) (← links)
• Pulmonary fibrosis: patterns and perpetrators (Q27694249) (← links)
• Role of the lysophospholipid mediators lysophosphatidic acid and sphingosine 1-phosphate in lung fibrosis (Q33756825) (← links)
• The mitochondrial cardiolipin remodeling enzyme lysocardiolipin acyltransferase is a novel target in pulmonary fibrosis (Q33901590) (← links)
• β-Arrestins regulate human cardiac fibroblast transformation and collagen synthesis in adverse ventricular remodeling (Q34603394) (← links)
• Integrating mechanisms of pulmonary fibrosis (Q35106452) (← links)
• Targeted disruption of β-arrestin 2-mediated signaling pathways by aptamer chimeras leads to inhibition of leukemic cell growth (Q35148896) (← links)
• A novel 3D high-content assay identifies compounds that prevent fibroblast invasion into tissue surrogates (Q35811284) (← links)
• Divergent β-arrestin-dependent signaling events are dependent upon sequences within G-protein-coupled receptor C termini (Q36579520) (← links)
• Ubiquitin-specific Protease 20 Regulates the Reciprocal Functions of β-Arrestin2 in Toll-like Receptor 4-promoted Nuclear Factor κB (NFκB) Activation (Q36755025) (← links)
• The inter-connection between fibrosis and microvascular remodeling in idiopathic pulmonary fibrosis: Reality or just a phenomenon. (Q36766700) (← links)
• Deficiency of β-arrestin1 ameliorates collagen-induced arthritis with impaired TH17 cell differentiation. (Q36820191) (← links)
• Suppression of von Hippel-Lindau Protein in Fibroblasts Protects against Bleomycin-Induced Pulmonary Fibrosis. (Q37088218) (← links)
• Fibrogenic Lung Injury Induces Non-Cell-Autonomous Fibroblast Invasion (Q37088303) (← links)
• Matrix Remodeling in Pulmonary Fibrosis and Emphysema. (Q37088316) (← links)
• Transcription factor TBX4 regulates myofibroblast accumulation and lung fibrosis (Q37137920) (← links)
• Mechanosensing by the α6-integrin confers an invasive fibroblast phenotype and mediates lung fibrosis (Q37191868) (← links)
• miR-323a-3p regulates lung fibrosis by targeting multiple profibrotic pathways. (Q37469185) (← links)
• Arrestins come of age: a personal historical perspective (Q38114209) (← links)
• β-Arrestins in the immune system (Q38114223) (← links)
• Multiple facets of cAMP signalling and physiological impact: cAMP compartmentalization in the lung (Q38166604) (← links)
• Investigational parathyroid hormone receptor analogs for the treatment of osteoporosis (Q38260285) (← links)
• β-Arrestin-biased AT1R stimulation promotes extracellular matrix synthesis in renal fibrosis (Q38713058) (← links)
• Hyaluronan and TLR4 promote surfactant-protein-C-positive alveolar progenitor cell renewal and prevent severe pulmonary fibrosis in mice. (Q38735180) (← links)
• Regulation of inflammation by β-arrestins: Not just receptor tales (Q39131811) (← links)
• G Protein-Coupled Receptor-G-Protein βγ-Subunit Signaling Mediates Renal Dysfunction and Fibrosis in Heart Failure. (Q39685882) (← links)
• β-Arrestin-1 deficiency protects mice from experimental colitis. (Q39692884) (← links)
• The Biocompatibility Manifesto: Biocompatibility for the Twenty-first Century (Q39734891) (← links)
• Angiotensin II receptors and peritoneal dialysis-induced peritoneal fibrosis (Q41195003) (← links)
• 3D pulmospheres serve as a personalized and predictive multicellular model for assessment of antifibrotic drugs (Q42328614) (← links)
• "Scar-cinoma": viewing the fibrotic lung mesenchymal cell in the context of cancer biology. (Q42594342) (← links)
• β-Arrestin-1 deficiency ameliorates renal interstitial fibrosis by blocking Wnt1/β-catenin signaling in mice (Q47425732) (← links)
• Identification of a small-molecule ligand of β-arrestin1 as an inhibitor of stromal fibroblast cell migration accelerated by cancer cells (Q48143870) (← links)
• Interaction of macrophages with apoptotic cells inhibits transdifferentiation and invasion of lung fibroblasts (Q49857850) (← links)
• Anti-fibrotic Effects of CXCR4-Targeting i-body AD-114 in Preclinical Models of Pulmonary Fibrosis. (Q49912722) (← links)
• FOXF1 Inhibits Pulmonary Fibrosis by Preventing CDH2-CDH11 Cadherin Switch in Myofibroblasts. (Q52720045) (← links)
• β-arrestin 1 regulates β2-adrenergic receptor-mediated skeletal muscle hypertrophy and contractility (Q60932658) (← links)
• Therapeutic Potential of Targeting ß-Arrestin (Q64056724) (← links)
• PD-L1 on invasive fibroblasts drives fibrosis in a humanized model of idiopathic pulmonary fibrosis (Q64066388) (← links)
• Vimentin intermediate filament assembly regulates fibroblast invasion in fibrogenic lung injury (Q64076917) (← links)
• Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets (Q64274792) (← links)
• Myofibroblasts in interstitial lung diseases show diverse electron microscopic and invasive features (Q84404009) (← links)
• Dopamine D2 receptor restricts astrocytic NLRP3 inflammasome activation via enhancing the interaction of β-arrestin2 and NLRP3 (Q88768074) (← links)
• The peripheral CB1 receptor antagonist JD5037 attenuates liver fibrosis via a CB1 receptor/β-arrestin1/Akt pathway (Q89524355) (← links)
• Regulation of cardiac fibroblast-mediated maladaptive ventricular remodeling by β-arrestins (Q91581869) (← links)
• β-arrestin2 deficiency protects against hepatic fibrosis in mice and prevents synthesis of extracellular matrix (Q95323178) (← links)
• β-Arrestin2 deficiency attenuates oxidative stress in mouse hepatic fibrosis through modulation of NOX4 (Q101051274) (← links)